CLINICAL_TRIALS
trial_result
· 2019-01-04
Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years [Phase 2]
Summary
Phase 2 trial evaluating safety, tolerability, and pharmacokinetics of oral treprostinil in pediatric pulmonary arterial hypertension patients aged 7 to 17. Res…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: United Therapeutics | Conditions: PAH | Phase 2 | Status: COMPLETED | Results posted: 2019-01-04